ALK and lung carcinoma: One of the first oncogenic drivers to be reported in lung cancer was the fusion of echinoderm microtubule-associated protein-like 4 (EML4) and anaplastic lymphoma kinase (ALK) (EML4-ALK) in 2007 [1].